Annual Current Assets
$440.04 M
+$70.27 M+19.00%
December 1, 2024
Summary
- As of March 2, 2025, TRDA annual total current assets is $440.04 million, with the most recent change of +$70.27 million (+19.00%) on December 1, 2024.
- During the last 3 years, TRDA annual current assets has risen by +$141.34 million (+47.32%).
- TRDA annual current assets is now at all-time high.
Performance
TRDA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$440.04 M
-$25.30 M-5.44%
December 1, 2024
Summary
- As of March 2, 2025, TRDA quarterly total current assets is $440.04 million, with the most recent change of -$25.30 million (-5.44%) on December 1, 2024.
- Over the past year, TRDA quarterly current assets has dropped by -$49.50 million (-10.11%).
- TRDA quarterly current assets is now -10.11% below its all-time high of $489.54 million, reached on June 30, 2024.
Performance
TRDA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
TRDA Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | -10.1% |
| 3 y3 years | +47.3% | +109.7% |
| 5 y5 years | +2423.6% | +109.7% |
TRDA Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +109.7% | -10.1% | +109.7% |
| 5 y | 5-year | at high | +2423.6% | -10.1% | +1001.5% |
| alltime | all time | at high | +2423.6% | -10.1% | +1001.5% |
Entrada Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $86.28 M(-13.2%) | $440.04 M(-5.4%) |
| Sep 2024 | - | $465.33 M(-4.9%) |
| Jun 2024 | - | $489.54 M(+18.2%) |
| Mar 2024 | - | $414.17 M(+12.0%) |
| Dec 2023 | $99.42 M(+135.7%) | $369.77 M(-3.5%) |
| Sep 2023 | - | $383.04 M(-1.8%) |
| Jun 2023 | - | $390.19 M(-10.1%) |
| Mar 2023 | - | $434.13 M(+106.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $42.18 M(+491.4%) | $209.88 M(-10.6%) |
| Sep 2022 | - | $234.73 M(-7.6%) |
| Jun 2022 | - | $253.90 M(-6.9%) |
| Mar 2022 | - | $272.71 M(-8.7%) |
| Dec 2021 | $7.13 M(+99.4%) | $298.70 M(+141.8%) |
| Sep 2021 | - | $123.53 M(-10.3%) |
| Jun 2021 | - | $137.64 M(+244.5%) |
| Dec 2020 | $3.58 M(+346.7%) | $39.95 M |
| Dec 2019 | $801.00 K | - |
FAQ
- What is Entrada Therapeutics annual total current assets?
- What is the all time high annual current assets for Entrada Therapeutics?
- What is Entrada Therapeutics annual current assets year-on-year change?
- What is Entrada Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly current assets year-on-year change?
What is Entrada Therapeutics annual total current assets?
The current annual current assets of TRDA is $440.04 M
What is the all time high annual current assets for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total current assets is $440.04 M
What is Entrada Therapeutics annual current assets year-on-year change?
Over the past year, TRDA annual total current assets has changed by +$70.27 M (+19.00%)
What is Entrada Therapeutics quarterly total current assets?
The current quarterly current assets of TRDA is $440.04 M
What is the all time high quarterly current assets for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total current assets is $489.54 M
What is Entrada Therapeutics quarterly current assets year-on-year change?
Over the past year, TRDA quarterly total current assets has changed by -$49.50 M (-10.11%)